Volumetric and angiogenic evaluation of antitumor effects with acoustic liposome and high-frequency ultrasound

Cancer Research

Volumn 71, Issue 22, 2011, Pages 6957-6964

  Kodama, Tetsuya ^a   Tomita, Noriko ^a   Yagishita, Yoko ^a   Horie, Sachiko ^a   Funamoto, Kenichi ^a   Hayase, Toshiyuki ^a   Sakamoto, Maya ^b   Mori, Shiro ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; CANCER INHIBITION; CONTROLLED STUDY; HIGH FREQUENCY ULTRASOUND; IMAGE ANALYSIS; IMAGE DISPLAY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; ULTRASOUND; VOLUMETRY;

ANIMALS; ANTIGENS, CD31; CELL LINE, TUMOR; CISPLATIN; IMMUNOHISTOCHEMISTRY; LIPOSOMES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 81155154269     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2389     Document Type: Article

References (35)

1. Palmowski M, Huppert J, Hauff P, Reinhardt M, Schreiner K, Socher MA, et al. Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment. Cancer Res 2008;68:7042-9.
2. Sboros V. Response of contrast agents to ultrasound. Adv Drug Deliv Rev 2008;60:1117-36.
3. du Toit LC, Govender T, Pillay V, Choonara YE, Kodama T. Investigating the effect of polymeric approaches on circulation time and physical properties of nanobubbles. Pharm Res 2011;28:494-504.
4. Hitchcock KE, Caudell DN, Sutton JT, Klegerman ME, Vela D, Pyne- Geithman GJ, et al. Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release 2010;144:288-95.
5. Klegerman ME, Wassler M, Huang SL, Zou Y, Kim H, Shelat HS, et al. Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics. J Control Release 2010;142: 326-31.
6. Kodama T, Aoi A, Watanabe Y, Horie S, Kodama M, Li L, et al. Evaluation of transfection efficiency in skeletal muscle using nano/microbubbles and ultrasound. Ultrasound Med Biol 2010;36: 1196-205.
7. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92. (Pubitemid 17221789)
8. Suzuki R, Takizawa T, Negishi Y, Hagisawa K, Tanaka K, Sawamura K, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007;117:130-6. (Pubitemid 46161862)
9. Funamoto K, Hayase T, Kodama T. Visualization of microcirculation based on brightness variation in contrast-enhanced ultrasound. ASME 2010 Summer Bioengineering Conference; 2010 June 16-19; Naples, Florida; 2010.
10. Kodama T, Tomita N, Horie S, Sax N, Iwasaki H, Suzuki R, et al. Morphological study of acoustic liposomes using transmission electron microscopy. J Electron Microsc (Tokyo) 2010;59:187-96.
11. Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2008;34:425-34. (Pubitemid 351625448)
12. Watanabe Y, Aoi A, Horie S, Tomita N, Mori S, Morikawa H, et al. Lowintensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008;99:2525-31.
13. Pysz MA, Foygel K, Panje CM, Needles A, Tian L, Willmann JK. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 2010;46:187-95.
14. U. S. National Institutes of Health. Available from: http://rsbweb.nih. gov/ij/.
15. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 2006;66:3303-9.
16. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006;95:1611-25. (Pubitemid 44950785)
17. Noguchi Y,WuJ, Duncan R, Strohalm J, Ulbrich K, Akaike T, et al. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 1998;89:307-14.
18. Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 2004;3:125-34.
19. Lyshchik A, Fleischer AC, Huamani J, Hallahan DE, Brissova M, Gore JC. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med 2007;26:1575-86. (Pubitemid 351519803)
20. Rayleigh L. The theory of sound. 2nd ed. New York: Dover Publication; 1945.
21. Hoff L, Sontum PC, Hovem JM. Oscillations of polymeric microbubbles: effect of the encapsulating shell. J Acoust Soc Am 2000; 107:2272-80. (Pubitemid 30194382)
22. Medwin H. Counting bubbles acoustically-review. Ultrasonics 1977;15:7-13.
23. Minnaert M. On musical air-bubbles and the sound of running water. Philosophical Magazine 1933;16:235-48.
24. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007;7:573-84. (Pubitemid 47106628)
25. Rebillard A, Tekpli X, Meurette O, Sergent O, LeMoigne-Muller G, Vernhet L, et al. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res 2007;67:7865-74. (Pubitemid 47281382)
26. Tan GH, Tian L, Wei YQ, Zhao X, Li J, Wu Y, et al. Combination of lowdose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 2004;112:701-6. (Pubitemid 39425953)
27. Zhong XS, Liu LZ, Skinner HD, Cao Z, Ding M, Jiang BH. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells. Biochem Biophys Res Commun 2007;358:92-8. (Pubitemid 46719085)
28. Jugold M, Palmowski M, Huppert J, Woenne EC, Mueller MM, Semmler W, et al. Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol 2008;18:753-8.
29. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
30. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9: 685-93. (Pubitemid 36749217)
31. Xuan JW, Bygrave M, Jiang H, Valiyeva F, Dunmore-Buyze J, Holdsworth DW, et al. Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound. Cancer Res 2007;67:2830-9. (Pubitemid 46548973)
32. Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. Radiology 2002;222: 460-7. (Pubitemid 34106120)
33. Fleischer AC, Niermann KJ, Donnelly EF, Yankeelov TE, Canniff KM, Hallahan DE, et al. Sonographic depiction of microvessel perfusion: principles and potential. J Ultrasound Med 2004;23:1499-506. (Pubitemid 39411255)
34. Gee MS, Saunders HM, Lee JC, Sanzo JF, Jenkins WT, Evans SM, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001;61:2974-82. (Pubitemid 32691943)
35. Lindner JR. Molecular imaging of cardiovascular disease with contrast- enhanced ultrasonography. Nat Rev Cardiol 2009;6:475-81.